Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Cigna to sell Medicare business to HCSC for $3.7bn

(Sharecast News) - The Cigna Group said on Wednesday that it has agreed to sell its Medicare business to Health Care Service Corporation (HCSC) for around $3.7bn. As part of the deal, which is expected to close in the first quarter of next year, HCSC will buy Cigna's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAllies businesses.

Cigna and HCSC have agreed to enter into a four-year services agreement under which Evernorth Health Services, a subsidiary of Cigna, will continue to provide pharmacy benefit services to the Medicare businesses, effective on closing of the transaction.

David M. Cordani, chairman and chief executive of Cigna, said: "The agreement will enable The Cigna Group to drive meaningful value for all our stakeholders, providing an enhanced ability to accelerate investment and growth in our services platform, while further deepening our commitment to our existing health benefits platform.

"In tandem, the transaction will position our Medicare businesses and CareAllies for additional growth as they continue to serve the needs of their customers as part of HCSC."

The deal is expected to be accretive to Cigna's adjusted earnings per share in 2025.

Also on Thursday, Cigna reaffirmed its 2024 outlook targeting consolidated adjusted income from operations on a per share basis of at least $28 for full-year 2024, and its long-term annual adjusted earnings per share growth target of 10 to 13%.

Share this article

Related Sharecast Articles

ECR Minerals mulls expansion into US helium market
(Sharecast News) - ECR Minerals, an exploration and development company traditionally focused on gold in Australia, announced on Friday that its board was exploring potential investments in producing helium assets in the United States.
Zenova reports solid momentum as interim loss narrows
(Sharecast News) - Fire safety and heat management technology specialist Zenova Group reported significant first-half strides in its interim results on Friday, despite a challenging financial backdrop.
Jefferies lowers target price on Life Science REIT
(Sharecast News) - Jefferies cut its price target on real estate investment trust Life Sciences REIT from 45.0p to 36.0p following a visit to the group's Cambourne Science & Technology Park.
Beowulf reports substantial first-half progress
(Sharecast News) - Mineral explorer and developer Beowulf Mining reported substantial progress across its portfolio in its interim results on Friday, particularly in advancing its key projects at Gállok in Sweden and the Graphite Anode Materials Plant (GAMP) in Finland.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.